XML 24 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
EMPLOYEE BENEFIT PLANS
9 Months Ended
Sep. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE BENEFIT PLANS
EMPLOYEE BENEFIT PLANS
Stock-Based Compensation Plans. The following table summarizes stock options and stock appreciation rights activity during the Third Quarter:
Stock Options and Stock Appreciation Rights
 
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
Outstanding at June 30, 2018
 
2,003

 
$
50.44

 
1.8
 
$
307

Granted
 

 

 
 
 
 
Exercised
 

 

 
 
 

Forfeited or expired
 
(57
)
 
86.66

 
 
 
 
Outstanding at September 29, 2018
 
1,946

 
49.37

 
1.7
 
212

Exercisable at September 29, 2018
 
1,377

 
$
54.25

 
1.7
 
$
212


 
The aggregate intrinsic value shown in the table above is before income taxes and is based on (i) the exercise price for outstanding and exercisable options/rights at September 29, 2018 and (ii) the fair market value of the Company’s common stock on the exercise date for options/rights that were exercised during the Third Quarter.
Stock Options and Stock Appreciation Rights Outstanding and Exercisable. The following tables summarize information with respect to stock options and stock appreciation rights outstanding and exercisable at September 29, 2018:

Cash Stock Appreciation Rights Outstanding
 
Cash Stock Appreciation Rights Exercisable
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted- Average Exercise Price
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
61

 
$
36.73

 
0.5
 
38

 
$
36.73


Stock Options Outstanding
 
Stock Options Exercisable
Range of
Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
$13.65 - $29.49
 
22

 
$
14.41

 
0.4
 
22

 
$
14.41

$36.73 - $70.12
 
40

 
38.40

 
1.4
 
40

 
38.40

$80.22 - $127.84
 
189

 
108.14

 
2.8
 
189

 
108.14

$128.29 - $131.46
 
6

 
130.80

 
3.4
 
6

 
130.80

Total
 
257

 
$
89.71

 
2.4
 
257

 
$
89.71


Stock Appreciation Rights Outstanding
 
Stock Appreciation Rights Exercisable
Range of
Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(in Thousands)
 
 
 
(in Years)
 
(in Thousands)
 
 
$13.65 - $29.49
 
48

 
$
29.49

 
5.8
 
32

 
$
29.49

$36.73 - $70.12
 
1,419

 
38.11

 
1.1
 
889

 
38.26

$80.22 - $127.84
 
156

 
93.85

 
3.6
 
156

 
93.85

$128.29 - $131.46
 
5

 
128.29

 
0.8
 
5

 
128.29

Total
 
1,628

 
$
43.49

 
1.5
 
1,082

 
$
46.45


 
Restricted Stock Units and Performance Restricted Stock Units. The following table summarizes restricted stock unit and performance restricted stock unit activity during the Third Quarter:
Restricted Stock Units
and Performance Restricted Stock Units
 
Number of Shares
 
Weighted-Average
Grant Date Fair
Value Per Share
 
 
(in Thousands)
 
 
Nonvested at June 30, 2018
 
3,266

 
$
18.13

Granted
 
20

 
25.61

Vested
 
(76
)
 
14.07

Forfeited
 
(51
)
 
13.71

Nonvested at September 29, 2018
 
3,159

 
$
18.35


 
The total fair value of restricted stock units vested during the Third Quarter was approximately $1.9 million. Vesting of performance restricted stock units is based on achievement of operating margin growth and achievement of sales growth and operating margin targets in relation to the performance of a certain identified peer group.